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Abstract
Background: Pseudomonas aeruginosa (PA) and Burkholderia cepacia complex (Bcc), commonly found in the lungs of cystic
fibrosis (CF) patients, often produce cyanide (CN), which inhibits cellular respiration. CN in sputa is a potential biomarker for
lung infection by CF pathogens. However, its actual concentration in the infected lungs is unknown.
Methods and Findings: This work reports observation of CN in the lungs of mice infected with cyanogenic PA or Bcc strains
using a CN fluorescent chemosensor (49,59-fluorescein dicarboxaldehyde) with a whole animal imaging system. When the
CN chemosensor was injected into the lungs of mice intratracheally infected with either PA or B. cepacia strains embedded
in agar beads, CN was detected in the millimolar range (1.8 to 4 mM) in the infected lungs. CN concentration in PA-infected
lungs rapidly increased within 24 hours but gradually decreased over the following days, while CN concentration in B.
cepacia-infected lungs slowly increased, reaching a maximum at 5 days. CN concentrations correlated with the bacterial
loads in the lungs. In vivo efficacy of antimicrobial treatments was tested in live mice by monitoring bacteriogenic CN in the
lungs.
Conclusions: The in vivo imaging method was also found suitable for minimally invasive testing the efficacy of antibiotic
compounds as well as for aiding the understanding of bacterial cyanogenesis in CF lungs.
Citation: Nam S-W, Chen X, Lim J, Kim SH, Kim S-T, et al. (2011) In Vivo Fluorescence Imaging of Bacteriogenic Cyanide in the Lungs of Live Mice Infected with
Cystic Fibrosis Pathogens. PLoS ONE 6(7): e21387. doi:10.1371/journal.pone.0021387
Editor: Tanya Parish, Queen Mary University of London, United Kingdom
Received February 9, 2011; Accepted May 26, 2011; Published July 7, 2011
Copyright:  2011 Nam et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was equally supported by the National Research Foundation of Korea (NRF) grants funded by the Korean Government (MEST) (Science
Research Center program 20100001480: National Research Lab program 2010-0018895: World Class University Program R31-2008-000-10010-0: Basic Science
Research Program R01-2008-000-20593-0). The first author was supported by Research Program-Grant 2010 of Ewha Womans University. The funders had nor o l e
in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: nanopark@ewha.ac.kr (SP); jyoon@ewha.ac.kr (JY)
Introduction
Cystic fibrosis (CF) is the most common genetic disease in
Caucasians [1]. Its main clinical features are excessive mucus
production, airway obstruction, chronic airway infection and
chronic inflammation, leading to severe bronchiectasis, irrevers-
ible lung damage and respiratory failure. Pseudomonas aeruginosa
(PA) is the most common pathogen and is detected in 60–80% of
patients’ cultures according to age [2]. PA releases virulence
factors that induce pulmonary deterioration in the lungs of CF
patients [3], including exotoxin A, elastase, LasA protease and
pyocyanin [4]. Burkholderia cepacia complex (Bcc), a group of at
least nine species including B. cepacia, is more dangerous to CF
patients than PA [5]. Bcc infection leads to the rapid
deterioration of a patient’s condition, termed ‘cepacia syndrome’,
and approximately 20% of these patients die from high fevers,
bacteremia and severe necrotizing pneumonia [6]. Bcc’s innate
multi-drug resistance to antibiotics is often associated with the
high mortality rates [3]. Bcc produces a variety of virulence
factors, such as proteases, lipases, hemolysins and exopolysac-
chride (EPS) [3].
Most PA and Bcc strains are capable of producing cyanide (CN)
[7,8], which binds ferric iron and inhibits the function of
cytochrome c oxidase in mitochondria. The lungs of CF patients
are typically in a microaerobic condition, where cyanogenic
pathogens survive through anaerobic respiration that can increase
CN production [7,9]. Although studies have not yet determined
whether CN alone aggravates the conditions of CF patients,
growing evidence suggests that it may be a predictor of PA
infection in the CF lung [10,11]. CN has been detected up to
130 mM in the sputa of CF and non-CF bronchiectasis patients
infected with PA [10] and has not been detected in the sputa of
patients without PA infection [10,11]. However, monitoring the
amount of CN produced by microorganisms in the lung is not easy
because sputum samples are not easily obtained from either
pediatric patients or small animals, such as mice.
While conventional imaging methods, such as X-ray and MRI
(magnetic resonance imaging) show the pathological state of the
PLoS ONE | www.plosone.org 1 July 2011 | Volume 6 | Issue 7 | e21387infected organs, in vivo molecular imaging [12] offers noninvasive
insight into living organisms and provides spatial and temporal
information of disease-related changes in the body. Optical
molecular imaging [13,14] can detect light emitted from
chemiluminescent or fluorescent probes and is relatively safe,
cheap and easy to handle compared with MRI or nuclear imaging.
Fluorescent chemosensors selectively bind to ions [15] or metals
[16], changing their emission or excitation/emission profiles. This
property has been exploited to study cell physiologies, such as
heavy metal transitions [16]. CN specific chemosensors were
developed [17–20], but their application was limited to detecting
CN in environmental samples, such as water. Recently, we have
successfully visualized CN in the nematode Caenorhabditis elegans
using chemosensors [21,22].
In this study, CN production was monitored and quantified in
the lungs of mice infected with PA or B. cepacia strains. For chronic
infections, mice were intratracheally infected with these strains
embedded in agar beads [23,24]. An ‘‘off-on’’ type CN
chemosensor was directly injected into the lungs before the whole
animal imaging. The effects of antimicrobial compounds on CN
production were visualized as well.
Materials and Methods
Synthesis and fluorescent assays of the CN sensor
The sensor was synthesized by a previously reported method
[25]. Fluorescein (4 g, 12 mmol), 10 mL CHCl3, 6 mL CH3OH
and 0.06 g 15-crown-5 were placed in a 100 mL flask to which
20 g 50% NaOH solution was carefully added at 55uC. The
mixture was stirred for 5 h. After cooling, it was acidified with
10 M H2SO4. The precipitates were collected and dried in
vacuum. Finally, the white solid product (142 mg, yield 3.0%) was
obtained by chromatography on a silica gel column using
CH3COOCH2CH3/CH2Cl2 (5:95, v/v) as eluent. Fluorescent
assays used test solutions of the sensor (3 mM) and a various
concentration of the sodium salts of different anions (CN
2,
H2PO4
2, HSO4
2,N O 3
2,C H 3CO2
2,F
2,C l
2,B r
2 and I
2)i n
HEPES buffer (0.01 M, pH 7.4, 33% CH3CN). Fluorescence
emission spectra were obtained using a RF-5301/PC spectro-
fluorophotometer (Shimadzu Co.).
Bacterial strains and CN determination in the bacterial
culture
All PA strains were grown overnight in LB medium (BD) at
37uC and 220 rpm. The mutant required gentamicin (Sigma
Chemical Co.). Supernatants were harvested at the optical density,
OD600=0.9 and CN was assayed using SpectroquantH CN
detection kits (Merck).
B. cepacia (KCTC 2966) was obtained from the Biological
Resource Center (Daejeon, Korea). It was grown in 470 bacteria
culture medium (Sigma-Aldrich) at 30uC and 220 rpm. The
supernatant was harvested at OD600=2.6 and CN was assayed
with the kit. To determine the amount of CN produced from B.
cepacia biofilm, 12 mL of a 1:10 dilution of the culture
(OD600=0.5) was inoculated in a Petri dish containing 48 g of
glass beads and CN was trapped in a separate dish containing 4 M
NaOH as described previously [8]. CN trapped in NaOH was
assayed using the CN detection kits (Merck).
Introduction of NaCN to the lungs
6-week-old female BALB/c nude mice (17 to 19 g) were
purchased from Orientbio Inc. (Seongnam, Korea). They were
treated in accordance with the university’s guidelines. The mice
were anesthetized by intraperitoneal (i.p.) injection with 10 mL
(each 0.25 mg tiletamine, zolazepam) zoletilH50 (Virbac, Carros,
France) using an insulin syringe (Shinchang medical co., Gumi,
Korea). Then, 40 mL of various concentrations of NaCN
(0.1 mM–1 M) were injected into their lungs using a syringe.
Infection with PA or B. cepacia
50 mL of bacterial suspension in agar beads containing
approximately 4.5610
6 CFU was inoculated into the anesthetized
mice via intratracheal instillation [23,24] using a 24-gauge
catheter (BD).
In vivo imaging
A multimodal-imaging system IS4000MM (Kodak) was used at
465 nm and an emission at 535 nm. After 40 mL of the CN sensor
(1 mM) was injected into the lungs of the anesthetized mice, the
animals were exposed for 10 sec. Two rectangular regions of
interest (ROI) with dimensions of 280 pixels (width)6222 pixels
(height) were manually drawn on each animal image with a
dimension of 800 pixels (width)61,400 pixels (height) using the
program Image J (NIH, USA). One of the regions was the
infectious or affected area, covering the lobes, for the signal
intensity; the other ROI, outside the infectious area, was for
background intensity. The value of the background intensity was
subtracted from the signal intensity in order to obtain the
normalized signal intensity from each image.
Ex vivo imaging of CN and biofilm in the lungs
20 mm thick lung samples on glass slides [26] were incubated
with the sensor (2 mM) and TRITC (tetramethyl-rhodamine-
isothiocyanate)-labeled concanavalin A (50 mg/mL) (Sigma-Al-
drich) for 5 min. The images were obtained using a confocal laser
scanning microscope (CLSM) (LSM510, Carl Zeiss) with 488 nm
excitation and 505–530 nm emission filters for the sensor and
543 nm excitation and 560–615 nm emission filters for conca-
navalin A-TRITC at 4006magnification.
In vivo efficacy testing of antimicrobial compounds and
CN antidote
Ceftazidime, ciprofloxacin and patulin were purchased from
Sigma-Aldrich. PA14-infected mice were treated with either
ceftazidime [26] (200 mg/kg), through tail vein (i.v.) injection, or
ciprofloxacin [26] (30 mg/kg), through oral administration, at
18 h after infection. Patulin [27] (50 mg) was injected into the mice
intraperitoneally (i.p.) once a day for 3 days. CN in the lung was
imaged 6 h. after the treatments. The mice infected with B. cepacia
were treated with either ceftazidime (200 mg/kg, i.v.) or patulin
(50 mg, i.p.) 5 days after infection. Hydroxocobalamin (B12a) [28]
was purchased from Sigma-Aldrich. B12a (70 mg/kg) was injected
directly into the mouse lungs that had been either injected with
0.1 M NaCN or infected with PA14.
Bacterial load determinations
The lungs that were obtained from the sacrificed mice were
homogenized in 1 ml of sterile PBS, plated in duplicates on BBL
TM
eosin methylene blue agar (BD) and incubated at 37uC for 18 h
prior to CFU determinations.
Cell death in the infected lung tissue
20 mm thick fresh frozen sections from the mice that were
previously either injected NaCN or infected with PA14 were
incubated on a 45uC hot plate for 2 h and then washed sequentially
with 100%, 95%, 70% ethanol and PBS. Samples were fixed with
3.7% buffered formaldehyde for 10 min. and washed with PBS. A
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Gaithersburg, MD, USA) was used to examine whether bacterio-
genic CN induced apoptosis in the infected lungs. As a positive
control,TACS-nucleasewasadded totissue sections,whichinduced
apoptosis. To examine necrotic cells, tissue sections were counter-
stained with 1.5 mM propidium iodide (Invitrogen).
Statistics
The data are reported as dot blots including every data points of
n independent mice and independent experiments. Significant
difference was calculated with one-way analysis of variance
(ANOVA) was with Bonferroni post-tests and defined as p,0.05
using an unpaired two-tailed t test [29] (Graphpad, La Jolla, CA,
USA).
Results
Sensitivity and selectivity of CN sensor in solution
The title sensor 49,59-fluorescein dicarboxaldehyde (Fig. 1a),
reported as an intermediate in previous work [30], was synthesized
Figure 1. Proposed mechanism of CN sensing with synthesized fluorescein dialdehyde as the CN sensor and the characterization of
the sensor in aqueous solution. (a) CN ions selectively attack carbonyl groups of fluorescein dialdehyde and the phenol protons can be
transferred to the developing alkoxide anion, resulting in the enhancement of fluorescence. (b) Fluorescence spectra of the sensor (3 mM) with
different concentrations of NaCN (1–1,000 eq.) in CH3CN/HEPES at room temperature. (c) Effect of pH on fluorescence spectra of the sensor (3 mM) in
the absence of CN at room temperature in 100% water. (d) Fluorescence spectra of the sensor (3 mM) with various anions (200 eq.) in CH3CN/HEPES at
room temperature. (e) Fluorescence intensity of the CN sensor (1 mM) with either supernatant obtained from PA14 culture in LB (O.D.=3.3, pH 7.4),
PBS (pH 7.4) containing pyocyanin (0.5 mM) or NaCN (1 mM). The graph represents the mean 6 standard deviation of three independent
experiments. (f) Fluorescence intensity of the CN sensor (1 mM) with NaCN (0.1 M) in PBS (pH 7.4) in the absence or presence of B12a (2.5 mM). The
graph represents the mean 6 standard deviation of three independent experiments.
doi:10.1371/journal.pone.0021387.g001
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fluorescently observe CN in lungs. The sensing mechanism
involved CN acting as a selective nucleophilic agent for o-
hydroxy-substituted aromatic aldehyde [31] and could thus attack
the carbonyl group, which was activated by phenol protons
(Fig. 1a). Protons were then transferred from phenol hydrogen to
the developing alkoxide anion, resulting in the fluorescence
enhancement (Fig. 1a). In HEPES buffer (0.01 M, pH 7.4,
33% CH3CN), the enhancement of fluorescence depended on CN
concentration (Fig. 1b). In 100% water, there was no significant
change in fluorescence intensities when pH was adjusted from 6.0
to 8.2 (Fig. 1c). The CN sensor selectively reacted with CN
2 ions
among the various other anions in HEPES buffer, such as F
2,
Cl
2,B r
2,I
2,H 2PO4
2, HSO4
2, ClO4
2,N O 3
2 and CH3COO
2
(Fig. 1d). The sensor did not react with PA14 supernatant or
pyocyanin, a toxin produced by PA (Fig. 1e). Its reactivity with
CN interfered with B12a [28], known to bind strongly with CN
(Fig. 1f). Taken together, these results indicate that the sensor
specifically binds to CN, enhancing its fluorescence in aqueous
solution.
In vivo fluorescence imaging of exogenous CN in mice
The sensor was prepared in dimethyl sulfoxide (DMSO), known
to have low toxicity [32]. Before applying the CN sensor into
mouse, its toxicity was tested by daily injecting 40 mL of the sensor
(1 mM) into the lungs of three mice for 10 days. The direct
injection of the sensor into the lobes did not cause vomiting or
death. During the period, the injected mice did not show any
differences in behavior relative to controls that had not been
injected with the sensor (data not shown).
In the following experiments, 40 mL of various concentrations of
NaCN (0.1 mM–1 M) and 40 mL of the CN sensor (1 mM) were
injected into anesthetized mice (Fig. 2a). Whole animal imaging
system was used to determine whether the sensor was capable of
visualizing the exogenous CN in the lungs. Strong fluorescence
was observed in lungs injected with NaCN (0.1 mM or higher),
whereas the fluorescence was not observed in the lungs without
NaCN (Fig. 2c and Figure S1), indicating that the sensor
selectively reacted with CN in the lungs. Region of interest (ROI)
analyses showed that the sensor’s fluorescence intensity the lungs
exhibited a linear response with respect to the concentration of
injected NaCN (Fig. 2b). The correlation coefficient of the linear
regression was 0.992 for 4 to 7 independent measurements, and
the detection limit was 0.1 mM NaCN (p=0.0026). The reaction
of the sensor with CN in mice was inhibited by B12a (Figure S2).
Short-term in vivo imaging of biogenic CN in the lungs of
mice infected with PA or B. cepacia
To chronically infect the mouse lungs, mice were intratracheally
infected with PA or B. cepacia strains embedded in agar beads
[23,24] (Fig. 3a). As shown in Fig. 3b, stronger fluorescence was
observed in PA14 [33] - or PAO1 [34] -infected lungs, compared
with either PA14 hcnC mutant [35] -, B. cepacia-infected or
uninfected lungs (CN sensor only or PA14 supernatant), when
Figure 2. In vivo imaging of CN in the lungs of live mice using the CN sensor. (a) Experimental scheme for the in vivo imaging in the mouse
lungs injected with NaCN. (b) Changes in fluorescence intensity as a function of NaCN concentration in the murine lungs. Four to seven mice were
used per treatment, and each dot in the graph represents a background-subtracted fluorescence intensity obtained from a mouse in each treatment
group after subtracting background fluorescence intensity. Total twenty seven mice were used. (c) In vivo images of CN in the mouse lungs after
injection with NaCN. The fluorescence intensity is shown in arbitrary units.
doi:10.1371/journal.pone.0021387.g002
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at 18 h. after the infection. The dose-response curve (Fig. 2b)o f
the fluorescence signals in the lungs was used to estimate CN
concentration in the lungs. Surprisingly, both PA strains produced
millimolar concentrations (1.8 to 2.9 mM) of CN in the lung
(Fig. 3c). Interestingly, the wild type PA14 produced stronger
signals than wild type PAO1. These in vivo data were verified by ex
vivo imaging results (Fig. 3d), which exhibited a similar tendency
in fluorescence intensity. The reaction of the sensor with CN in
PA14-infected lungs was inhibited by B12a (Figure S2). Although
intranasal application of the sensor appeared to be least invasive, it
was not used in this study as it caused vomiting, and thus required
a high volume (ca. 200 mL) of the sensor in the infected mice
(Figure S3). In contrast, direct injection of the sensor in the lung
did not cause vomiting and 40 mL of the sensor (1 mM) generated
the highest signal to noise ratio to bacteriogenic CN (Figure S4).
Long-term in vivo imaging of biogenic CN in lungs of
mice infected with PA or B. cepacia
In vivo imaging was used to monitor CN production in the lungs
of live mice infected with either wild type PA14 or B. cepacia strains
for up to 9 days. In PA14-infected lungs, CN concentration rapidly
increased within 24 hours but gradually decreased over the
following days (Fig. 4a,c). In contrast, in B. cepacia-infected lungs,
CN concentration slowly increased, reaching a maximum at 5
days, after which it remained constant (Fig. 4b,d). Irrespective of
this difference in CN production pattern between PA14 and B.
cepacia strains, both strains were able to continuously produce
millimolar concentrations of CN in the lung even 7 days after
infection (Fig. 4c,d), indicating that the lungs were chronically
infected with the strains.
Tunnel assay showed that the apoptotic signal was stronger than
the necrotic signal when lungs were injected with 1 mM NaCN,
while the reverse occurred with injection of 10 mM NaCN
(Fig. 4e), indicating that the mode of cell death depended on CN
concentration. Lung sections of mice infected with PA14 for 18 h.
also revealed stronger necrotic signals (Fig. 4e), implying that the
CN concentration in the PA14-infected lungs was higher than
1 mM. CN concentration-dependent death mode has been
reported in cultured primary rat cortical cells [36]. The ex vivo
imaging results show that the bacteria in the lungs produced a
large amount of CN as well as EPS (Figure S5), a major
constituent of bacterial biofilm.
In vivo efficacy of antimicrobial compounds against PA
and B. cepacia infections
When mice infected with wild type PA14 were treated with either
ceftazidime (200 mg/kg) or ciprofloxacin (30 mg/kg) [26] at 18 h.
after infection, both CN production (Fig. 5a,b) and bacterial load
(Fig. 5c) in the lungs significantly decreased (p,0.0001), indicating
that the antibiotic treatments were effective against the lung
infection. Both CN production and bacterial loads significantly
decreased (p,0.0001) when mice infected with PA14 for 18 h were
treated with patulin (50 mg) [27], a fungal toxin that inhibits
bacterial communication, for 3 days intraperitoneally, indicating
that the toxin was capable of inhibiting the infection in vivo.
In contrast, the individual antibiotic treatments were not
effective against B. cepacia infection. Neither CN production nor
Figure 3. In vivo and ex vivo images of bacteriogenic CN in the lungs of live mice infected with PA or B. cepacia strains. (a) Experimental
scheme for the in vivo imaging of bacteriogenic CN in the murine lungs. (b) In vivo images of CN in the lungs at 18 h. after infection. The images in
the upper and lower panels are inverted fluorescence images and their corresponding reconstructed color images, respectively. (c) Quantification of
the fluorescence intensity in the lungs of the infected mice. Every three mice were used per treatment and each dot in the graph represents a
background-subtracted fluorescence intensity from a mouse in each treatment group. ANOVA with Bonferroni post-tests (p,0.0001, n=15). (d) CLSM
images of the cryo-sectioned lung tissue. Before imaging, 20 mm thick lung tissue samples were incubated with the sensor (2 mM) for 5 min. Scale
bar=50 mm.
doi:10.1371/journal.pone.0021387.g003
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PLoS ONE | www.plosone.org 5 July 2011 | Volume 6 | Issue 7 | e21387Figure 4. Long-term monitoring of CN production in the lungs of mice infected with PA14 or B. cepacia and tunnel assays of the lung
sections. (a) In vivo images of CN at various incubation times (1 h.–7 days) after PA14 infection. (b) In vivo images of CN at various incubation times
(1 h.–7 days.) after B. cepacia infection. (c) Quantification of the fluorescence intensity in the PA14-infected lungs. Each dot represents a background-
subtracted fluorescence intensity from a mouse in each treatment group, and every three mice were given each treatment (total n=15). (d)
Quantification of the fluorescence intensity in the B. cepacia-infected lungs. Each dot represents a background-subtracted fluorescence intensity from
a mouse in each treatment group, and every three mice were given each treatment (total n=18). (e) CLSM images of the 20 mm thick cryo-sectioned
lung tissue samples after tunnel assay using a TACSH 2 TdT-Fluor in situ apoptosis detection kit and incubation with 1.5 mM propidium iodide. TACS-
nuclease treatment before tunnel assay was used as a positive control. The sections from the murine lungs injected with 1, 10 mM NaCN or infected
with PA14 for 18 h. Scale bar=20 mm.
doi:10.1371/journal.pone.0021387.g004
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PLoS ONE | www.plosone.org 6 July 2011 | Volume 6 | Issue 7 | e21387Figure 5. The effects of antimicrobial treatments on CN production in infected lungs. (a) In vivo images of CN in the lungs of PA14-
infected mice treated with antibiotics. 18 h. post infection either 200 mg/kg ceftazidime was injected in the tail vein (i.v.) or 30 mg/kg ciprofloxacin
was orally administered using a 24-gauge catheter (p.o.). 50 mg patulin was treated intraperitoneally (i.p.) daily for 3 days. The sensor was then
directly injected into the lungs at 6 h. after the antibiotic treatment. (b) Quantification of the fluorescence intensity in the PA14-infected lungs treated
with antibiotics. Each dot represents a CN concentration from a mouse in each treatment group, and every three mice were given each treatment
(total n=15). ANOVA with Bonferroni post-tests (p,0.0001). The efficacy of each antibiotics against PA14 infection was determined using Student’s
unpaired t-test: ceftazidime, p,0.0001: ciprofloxacin, p=0.0029: patulin for 3 days, p,0.0001. (c) Reduced bacterial loads in the PA14-infected lungs
after each antimicrobial treatment. The PA14-infected lungs were excised from the mice at 6 h. after the antibiotic treatment and CFUs in the excised
lungs were determined. Each dot represents the mean CFU of four different lung samples from independent mice and three independent
experiments were performed per treatment. ANOVA with Bonferroni post-tests (p,0.0001). (d) In vivo images of CN in B. cepacia-infected lungs
treated with antibiotics. 200 mg/kg ceftazidime was injected into the tail vein, 30 mg/kg ciprofloxacin was orally administered, and 50 mg patulin was
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(Fig. 5d–f), indicating that the B. cepacia strain was resistant to
all the antibiotic treatments.
Discussion
The CN sensor was highly specific for CN both in vitro and in
vivo. Only CN induced fluorescence enhancement of fluorescein
dicarboxyaldehyde among various anions in aqueous solution
(Fig. 1d). This selectivity was attributable to the specific reaction
between the aldehyde group of the sensor and CN (Fig. 1a). The
aldehyde group allows intramolecular hydrogen bonding, thereby
facilitating nucleophilic attack from CN. The specificity of the
sensor to CN in aqueous solution was further verified by results
showing that its fluorescence response to CN was not affected by
either PA14 supernatant or pyocyanin (Fig. 1e), while it was
reduced by a CN antidote, B12a [28] (Fig. 1f). Similarly, hcnC
mutant strain did not induce any fluorescent signal in the infected
lung (Fig. 3b,c) and B12a was able to interfere with the reaction
of the sensor with CN in the lung (Figure S3), demonstrating the
in vivo specificity of the sensor to CN. It is expected that
physiological pH (6.9) in the lung [37] would not affect the
fluorescence response of the sensor, as there was no significant
difference in the fluorescence intensities of the sensor over the pH
range 6.0–8.2 (Fig. 1c). Using the sensor and whole animal
imaging, concentrations as low as 0.1 mM NaCN were observed
in the lung (Fig. 2).
The presence of CN at high concentrations (1.8 to 4 mM)
allowed visualization of bacteriogenic CN in the lungs of live
mice infected with PA or B. cepacia strains. These strains in the
lung produced more CN than they did in the planktonic culture
(Table S1). CN production by PA or B. cepacia strains might be
enhanced by a microaerophilic condition in the infected lungs,
where HCN synthases are highly activated [7,9]. The micro-
aerophilic condition in the lung might have been contributed by
biofilm formation (Figure S5). Especially, B. cepacia is known to
produce CN only when it establishes mature biofilm [8]. This
may explain why it did not produce detectable amounts of CN in
the lung until 2–3 days after infection (Fig. 4b). Once it started
to produce CN, its CN production was continued even at 9 day
after infection (Fig. 4b,d). These results suggest that CF lung,
which is microaerophilic, is suited for the cyanogenic bacteria to
produce CN.
Cell death by necrosis (Fig. 4e) indicates the presence of
millimolar CN in the infected lungs. It was shown that CN at
1 mM or higher concentrations caused necrosis in epithelial
lung cells [38]. Other major virulence factors including
pyocyanin in PA are known to apoptosis in the lung [39,40].
The CN concentration (2.9 mM) in the murine lungs infected
with PA14 can be converted to be 1.7 mg/kg, a fifth of the
lethal dose (8.4 mg/kg) in mice [41]. At this concentration, CN
was capable of inhibiting cytochrome oxidase activity by up to
15%, causing unconsciousness in the mice for 10 to 60 min [42].
In fact, many of the infected mice vomited and did not eat for
two days, some died (data not shown). Necrosis in the lung has
b e e nr e p o r t e dt oe n h a n c ei n f l a m m a t i o na tt h es i t eo fi n f e c t i o n
[43]. These data suggest that, along with other virulence factors,
biogenic CN in the lungs may have detrimental effects in CF
patients.
CN concentration in the lungs was clearly related to the
respective bacterial loads (Fig. 5), suggesting that bacteriogenic
CN acted as a biomarker of the cyanogenic bacteria in the lungs.
Information about the effective route of antibiotic administration,
as well as the in vivo efficacy of the antibiotics, was obtained from
this correlation (Fig. 5). PA14 was susceptible to b-lactam (e.g.,
ceftazidime) or fluoroquinolone (e.g., ciprofloxacin) antibiotics as
well as patulin (Fig. 5a–c). Patulin inhibits quorum sensing [44],
which allows bacteria to produce responses such as virulence
factors or biofilm at a critical cell density. PA has been reported to
be effectively cleared from mice by treatment with patulin [27]. In
contrast, B. cepacia was resistant to all the antimicrobial treatments
(Fig. 5d–f). This is possible because it has b-lactamase as well as
antibiotic efflux system [45]. These results suggest that the current
CN imaging method is suitable for testing the in vivo efficacy of
antibacterial compounds and CN inhibitors. The method has
several advantages in testing antibiotic susceptibility of PA in vivo
over the in vivo imaging method using luciferase-tagged isolates
[46,47]. Unlike the latter, the former does not require a
construction of a strain carrying the luciferase gene and its
fluorescence signal is not affected by exhaustion of flavin
mononucleotide, which is a substrate of luciferase [46,47].
Collectively, these results suggest that the chemosensor-based in
vivo imaging method is useful for fast and convenient animal testing
of drug efficacy against the PA and B. cepacia infections as well as
understanding cyanogenesis in CF lungs. In future, a CFTR-
deficient murine model [48] could be used to elucidate the
pathological role of biogenic CN in CF patients.
Supporting Information
Figure S1 Representative in vivo inverted fluorescence images
and their corresponding reconstructed color images (top and
bottom respectively) of the mice that were injected with various
concentrations of NaCN (0.1 mM–1 M). Then, 40 uL of the CN
sensor (1 mM) were injected into the lung of the mice for in vivo
imaging.
(DOCX)
Figure S2 Inhibition of exogenous and bacteriogenic CN by a
CN antidote, hydroxocobalamin (B12a). The mice were either
injected with 40 mL of NaCN (0.1 M) or infected with PA14 for
18 h. Then, 40 mL of B12a (70 mg/kg, 24.9 mM) were addition-
ally injected into the mice before the imaging.
(DOCX)
Figure S3 In vivo imaging of CN in the lung of PA14-infected
mice using the cyanide sensor with the intranasal application. (a)
A 24-gauge catheter containing 50 mL of the cyanide sensor
(1 mM) was introduced into the nostril of the mouse that was not
infected with PA14 (control). 50–200 mLo ft h eC Ns e n s o r
(1 mM) was injected into the lung of PA14-infected mice through
the intranasal application at 18 h. post infection. (b) Changes in
the fluorescence intensity as a function of the volume (50 to
200 mL) of the CN sensor that was introduced through the
intranasal application into the lungs of the mice infected with
intraperitoneally administered (i.p.) daily for 5 days after infection. (e) Quantification of the fluorescence intensity in the lungs of the B. cepacia-
infected mice treated with antibiotics. Each dot represent a CN concentration from a mouse in each treatment group and three mice were used per
each treatment (total n=12). ANOVA with Bonferroni post-tests (p=0.8760). (f) B. cepacia loads in the lungs treated with the antibiotics. Each data
point represents the mean CFU of four different lung samples from independent mice and three independent experiments were performed per
treatment. ANOVA with Bonferroni post-tests (p=0.1040).
doi:10.1371/journal.pone.0021387.g005
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independent measurements.
(DOCX)
Figure S4 Effect of the volume of the CN sensor on in vivo
cyanide imaging. (a) Various volumes (0–100 mL) of the CN sensor
(1 mM) were injected into the lung of mice infected with PA14.
The images in the upper and lower panels are the inverted
fluorescence images and their corresponding reconstructed color
images, respectively. (b) Changes in the fluorescence intensity as a
function of the injected volume of the cyanide sensor in the lung of
mice infected with PA14. (c) Signal to noise (S/N) ratio of the
fluorescence signal in the mouse lungs with respect to the injected
volume of the cyanide sensor. The S/N ratio was defined as the
ratio of the fluorescent signal value in the mouse lung infected with
PA14 to the signal value without the PA14 infection. All of the
data are given as the mean 6 standard deviations (s.d.) of n
independent measurements.
(DOCX)
Figure S5 Ex vivo imaging of CN and biofilm in the lungs of the
mice infected with PA14 or B. cepacia strains for various times.
CLSM images of the 20 mm thick cryo-sections incubated with
2 mM CN sensor for 5 min and 50 mg/mL concanavalin A-
TRITC for 5 min. The surface plot image of merged images was
obtained using Imaris
TM program. Scale bar 220 mm.
(DOCX)
Table S1 CN production in liquid and solid cultures and murine
lungs by PA and B. cepacia strains. CN in the liquid cultures was
determined using the SpectroquantH method* in triplicate (at
OD600=0.9 for PA, 2.6 for B. cepacia). CN in the solid cultures
containing glass beads were trapped in 4 M NaOH and measured
using the method described above. Means 6 standard deviations
of three independent experiments are shown (n. d.=not detected).
Biogenic CN in the lungs previously infected with PA and B.
cepacia was determined from the images using a multimodal-
imaging system (IS4000MM, Kodak). The standard curve
(Fig. 2b) was used to determine the concentration of biogenic
CN in the lungs infected with either PA or B. cepacia. *Detailed
description in the methods.
(DOCX)
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